1.Batalov, I. and Feinberg, A.W. 2015. Differentiation of cardiomyocytes from human pluripotent stem cells using monolayer culture: supplementary issue: stem cell biology. Biomarker insights, 10, pp.BMI-S20050.

2.Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K. and Leri, A., 2003. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6): 763-776.

3.Blau, H.M., Brazelton, T.R. and Weimann, J.M. 2001. The evolving concept of a stem cell: entity or function?. Cell, 105(7): 829-841.

4.Cloos, P.A., Christensen, J., Agger, K. and Helin, K. 2008. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev., 22(9): 1115-1140.

5.Davis, B.H., Morimoto, Y., Sample, C., Olbrich, K., Leddy, H.A., Guilak, F. and Taylor, D.A. 2012. Effects of myocardial infarction on the distribution and transport of nutrients and oxygen in porcine myocardium. J. Biomech. Eng., 134(10): 101-105.

6.Franco, D., Lamers, W.H. and Moorman, A.F. 1998. Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model. Cardiovasc. Res., 38(1): 25-53.

7.Franco, D., Markman, M.M., Wagenaar, G.T., Ya, J., Lamers, W.H. and Moorman, A.F. 1999. Myosin light chain 2a and 2v identifies the embryonic outflow tract myocardium in the developing rodent heart. Anat. Rec. 254: 135–146

8.Fukuda, K. 2003. Regeneration of cardiomyocytes from bone marrow: use of mesenchymal stem cell for cardiovascular tissue engineering. Cytotechnology, 41(2-3): 165-175.

9.Fukuda, K. 2003. Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes. Bone Marrow Transplant 32: S25–S27.

10.Haaf, T. and Schmid, M. 2000. Experimental condensation inhibition in constitutive and facultative heterochromatin of mammalian chromosomes. Cytogenet. Genome Res., 91(1- 4): 113-123.

11.Haaf, T. and Schmid, M. 2000. Experimental condensation inhibition in constitutive and facultative heterochromatin of mammalian chromosomes. cytogenetic and genome research., 91: 113–123.

12.Hailstones, D., Barton, P., Chan-Thomas, P., Sasse, S., Sutherland, C., Hardeman, E. and Gunning, P. 1992. Differential regulation of the atrial isoforms of the myosin light chains during striated muscle development. J. Biol. Chem., 267(32): 23295-23300.

13.Karakikes, I., Ameen, M., Termglinchan, V. and Wu, J.C. 2015. Human induced pluripotent stem cell–derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes. Circ. Res., 117(1): 80-88.

14.Knollmann, B.C. 2013. Induced pluripotent stem cell–derived cardiomyocytes: Boutique science or valuable arrhythmia model?. Circ. Res., 112(6): 969-976.

15.Kubalak, S.W., Miller-Hance, W.C., O’Brien, T.X., Dyson, E. and Chien, K.R., 1994. Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. J. Biol. Chem., 269: 16961–16970.

16.Laflamme, M.A. and Murry, C.E., 2011. Heart regeneration. Nature, 473(7347): 326-335.

17.Lee, A.S., Xu, D., Plews, J.R., Nguyen, P.K., Nag, D., Lyons, J.K., Han, L., Hu, S., Lan, F., Liu, J. and Huang, M. 2011. Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells. J. Biol. Chem., 286 (37): 32697-32704.

18.Lundy, S. D., Zhu, W. Z., Regnier, M. and Laflamme, M.A. 2013. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev., 22(14): 1991-2002.

19.Lyons, G.E. In situ analysis of the cardiac muscle gene program during embryogenesis. 1994. Trends Cardiovasc Med., 4: 70–77.

20.Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K., Maier, L.S., Nguemo, F., Menke, S., Haustein, M., Hescheler, J. and Hasenfuss, G. 2008. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation, 118(5): 507.

21.Medvedev, S.P., Shevchenko, A.I. and Zakian, S.M. 2010. Induced pluripotent stem cells: problems and advantages when applying them in regenerative medicine. Acta Naturae, 2(2): 18–28.

22.Moran, A.E., Forouzanfar, M.H., Roth, G.A., Mensah, G.A., Ezzati, M., Murray, C.J. and Naghavi, M. 2014. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation, 129(14): 1483-1492.

23.Mummery, C.L., Zhang, J., Ng, E.S., Elliott, D.A., Elefanty, A.G., and Kamp, T.J. 2012. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res., 111(3): 344-358.

24.Murry, C.E., Reinecke, H. and Pabon, L.M. 2006. Regeneration gaps: observations on stem cells and cardiac repair. J. Am. Coll. Cardiol., 47(9): 1777-1785.

25.O’Brien, T.X., Lee, K.J. and Chien, K.R. 1993. Positional specification of ventricular myosin light chain 2 expression in the primitive murine heart tube. Proc. Natl. Acad. Sci., 90: 5157–5161.

26.Shimada, H., Nakada, A., Hashimoto, Y., Shigeno, K., Shionoya, Y. and Nakamura, T., 2010. Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol. Reprod. Dev., 77(1): 2-2.

27.Singh, P., Mondal, T., Kumar, K., Das, K., Mahalakshmi. N., Madhusoodan. A.P. and Bag, S. 2019. Expression of Cardiac Specific Cell Marker in Ex Vivo Differentiated Canine iPSC. Indian J. Anim. Res., B-3829:1-5.

28.Stadtfeld, M., Apostolou, E., Akutsu, H., Fukuda, A., Follett, P., Natesan, S. and Hochedlinger, K. 2010. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature, 465(7295): 175

29.Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131(5): 861-872.

30.Takahashi, T., Lord, B., Schulze, P.C., Fryer, R.M., Sarang, S.S., Gullans, S.R., and Lee, R.T. 2003. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation, 107(14): 1912-1916

31.Tsuji-Takayama, K., Inoue, T., Ijiri, Y., Otani, T., Motoda, R., Nakamura, S. and Orita, K. 2004 Demethylating agent, 5- azacytidine, reverses differentiation of embryonic stem cells. Biochem. Biophys. Res. Commun., 323 :86–90.

32.Vaskova, E.A., Stekleneva, A.E., Medvedev, S.P., and Zakian, S.M. 2013. “Epigenetic memory” phenomenon in induced pluripotent stem cells. Acta Naturae, 5(4): 19-24.

33.Wess, G., Domenech, O., Dukes-McEwan, J., Häggström, J. and Gordon, S. 2017. European Society of Veterinary Cardiology screening guidelines for dilated cardiomyopathy in Doberman Pinschers. J. Vet. Cardiol., 19(5): 405-415.

34.Wu, Y.J., Chen, S.Y., Chang, S.J. and Kuo, S.M. 2013. Enhanced differentiation of rat MSCs into cardiomyocytes with 5-azacytidine/collagen I nano-molecules. In: Proceedings of 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), pp 322-325.

35.Yoshida, Y. and Yamanaka, S. 2011. iPS cells: a source of cardiac regeneration. J. Mol. Cell. Cardiol., 50(2): 327-332.